Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saving Sight is a U.S. nonprofit eye bank and healthcare organization that facilitates eye donation, processes and distributes donor corneal tissue, and provides services that support corneal transplantation and related ophthalmic care. Founded in 1960 and headquartered in Kansas City, Missouri, it operates across Missouri, Kansas, and Illinois and describes itself as one of the nation’s leading eye banks. In addition to core eye-banking operations, the organization offers tissue-processing services, surgeon support, training resources, charitable vision programs, and a donor services center. Saving Sight also launched First Gift, a division focused on birth tissue donation, expanding its activities beyond corneal transplantation into broader tissue-donation services. The organization appears to commercialize or distribute ophthalmic solutions such as BrightMEM through partnerships and investment relationships rather than operating like a traditional drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saving Sight.